7月16日，Elevance Health盘前上涨3.07%，报402.33美元/股，成交额9.04万美元。公司前一交易日因营业利润率收窄引发抛售，盘中一度下挫逾8%，当前呈现技术性反弹。
消息面上，公司7月15日发布的Q2财报显示调整后每股收益7.45美元，超市场预期6.21美元约20%；营收498.3亿美元，超预期约12亿美元；同时上调全年调整后每股收益指引至至少27美元。此外，管理层在电话会议中确认联邦医疗保险机构不会对其处方药计划实施制裁，缓解部分监管担忧。当前管理型保健护理板块整体回暖，联合健康涨6.82%，哈门那涨5.71%，板块联动提振市场情绪。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.